Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

8:00 AM ET 8-K
M&A Deal First Seacoast Bancorp, Inc. FSEA

First Seacoast Bancorp M&A Deal with Cambridge Financial Group, Inc.

First Seacoast Bancorp, Inc. announced it has received the final regulatory approvals and waivers required to complete its merger with Cambridge Financial Group, Inc. The transaction, which includes the merger of First Seacoast Bank into Cambridge Savings Bank, is expected to close on October 1, 2026.

Counterparty
Cambridge Financial Group, Inc.
8:00 AM ET 8-K
Investor Presentation Aquestive Therapeutics, Inc. AQST

Aquestive Therapeutics Investor Presentation

Aquestive Therapeutics filed a corporate investor presentation dated September 23, 2026, to be used in meetings with institutional investors and analysts. The presentation provides updates on the company's AdrenaVerse pipeline, including the regulatory status of Anaphylm (epinephrine) sublingual film following its NDA resubmission to the FDA and the development of AQST-108 for dermatologic indications.

7:52 AM ET 8-K
Other 8-K Filing Corteva, Inc. CTVA

Corteva Other 8-K Filing

Corteva announced that the SEC has declared effective the Form 10 registration statement for the spin-off of its advanced seed and genetics business, Vylor, into an independent publicly traded company. The separation is expected to be completed on October 1, 2026, with Corteva stockholders receiving one share of Vylor (NYSE: VYLR) for every share of Corteva held as of the September 24 record date.

Counterparty
Vylor
7:52 AM ET 8-K
Other 8-K Filing Vylor Inc. VYLR

Vylor Other 8-K Filing

Vylor Inc. announced that its Form 10 registration statement has been declared effective by the SEC, clearing the way for its spin-off from Corteva, Inc. into an independent, publicly traded company. The separation is expected to be completed on October 1, 2026, with Corteva stockholders receiving one share of Vylor common stock for every share of Corteva held as of the September 24 record date.

Counterparty
Corteva, Inc.
7:47 AM ET Form 4
Insider Selling Similarweb Ltd. SMWB

Similarweb CEO Or Offer Sells $876K of Stock

Or Offer, CEO, sold 113,900 shares of Similarweb Ltd. at $7.69 a share, worth $876K in total on Sep 24, 2026. Shares held after the trade: 3,930,881 (-2.8%).

Value
$876K
Shares
113,900
Price
$7.69
Role
CEO
Holding change
-2.8%
Trade date
Sep 24, 2026
7:39 AM ET 8-K
Investor Presentation Quantum Cyber N.V. QUCY

Quantum Cyber Investor Presentation

Quantum Cyber N.V. released an updated corporate investor presentation and press release detailing a sharpened strategic focus on quantum navigation, interceptor drones, and U.S.-based manufacturing. The company is concentrating its 'System-of-Systems' platform on three pillars: unjammable quantum antenna technology, one-way attack drones, and the MAHCA operating system for autonomous swarm behavior.

7:31 AM ET 8-K
M&A Deal Blue Acquisition Corp BACC

Blue Acquisition M&A Deal with Blockfusion USA, Inc.

Blue Acquisition Corp. (BACC) provided an updated investor presentation regarding its pending business combination with Blockfusion USA, Inc. The transaction, originally announced in November 2025, will result in both companies becoming subsidiaries of a new publicly traded entity, Blockfusion Digital Infrastructure, Inc. (Pubco).

Counterparty
Blockfusion USA, Inc.
7:05 AM ET 8-K
Clinical Trial Data C4 Therapeutics, Inc. CCCC

C4 Therapeutics Clinical Trial Data

C4 Therapeutics presented new biomarker data from its Phase 1 trial of cemsidomide with dexamethasone and preliminary Phase 1b data for cemsidomide combined with elranatamab at the 23rd International Myeloma Society Annual Meeting. The data demonstrated that cemsidomide drives T-cell activation and prevents T-cell exhaustion, supporting its potential as a combination partner for immune-based therapies in relapsed/refractory multiple myeloma. Additionally, the 75 µg dose level in the Phase 1b trial was declared safe, allowing the study to advance to dose expansion and escalation cohorts.

7:01 AM ET 8-K
Leadership Change Factset Research Systems Inc FDS

Factset Research Systems Leadership Change

FactSet Research Systems Inc. appointed Marcel Prins to its Board of Directors, effective September 23, 2026. Prins brings over 25 years of experience in operations, technology, and asset management, having previously served as COO of Robeco and APG Asset Management. He will participate in the company's existing non-employee director compensation program.

Counterparty
Marcel Prins
7:00 AM ET 8-K
Capacity Expansion Atlas Energy Solutions Inc. AESI

Atlas Energy Solutions Capacity Expansion

Atlas Energy Solutions entered into purchase commitments for 283 MW of incremental Caterpillar natural gas generation equipment and an additional 328 MW of generating capacity for 2027 deliveries. These equipment purchases are backed by cost reimbursement agreements with a leading frontier AI lab to support the deployment of power infrastructure for specific data center projects.

Counterparty
Caterpillar Inc.
7:00 AM ET 8-K
Court & Legal Update Nektar Therapeutics NKTR

Nektar Therapeutics Court & Legal Update

A jury in the U.S. District Court for the Northern District of California awarded Nektar Therapeutics $90 million in damages plus interest in its lawsuit against Eli Lilly. The jury found that Lilly breached the implied covenant of good faith and fair dealing regarding the license agreement for rezpegaldesleukin. The verdict remains subject to post-trial proceedings and potential appeals.

Counterparty
Eli Lilly and Company
7:00 AM ET 8-K/A
Shareholder Meeting Aebi Schmidt Holding AG AEBI

Aebi Schmidt Holding Shareholder Meeting

Aebi Schmidt Holding AG filed an amendment to its 2026 Annual General Meeting results to disclose the board's decision on the frequency of executive compensation votes. Following shareholder preference, the company will hold a non-binding advisory 'say-on-pay' vote every year. The next required vote on this frequency will occur no later than the 2032 annual meeting.

6:13 AM ET Form 4
Insider Selling Sea Ltd SE

Sea CCO and GC Yanjun Wang Sells $241K of Stock

Yanjun Wang, CCO and GC, sold 2,358 shares of Sea Ltd at $100.86 to $103.46 a share (average $102.04) in 5 transactions, worth $241K in total between Sep 23, 2026 and Sep 24, 2026. Shares held after the trade: 94,022 (-0.6%).

Value
$241K
Shares
2,358
Average price
$102.04
Role
CCO and GC
Holding change
-0.6%
Trade date
Sep 23, 2026 to Sep 24, 2026
6:07 AM ET Form 4
Insider Buying Intercont (Cayman) Ltd NCT

Intercont (Cayman) CEO and Chairman Muchun Zhu Buys $650K of Stock

Muchun Zhu, CEO and Chairman, bought 1,625,000 shares of Intercont (Cayman) Ltd at $0.4 a share, worth $650K in total on Sep 25, 2026. Shares held after the trade: 1,831,598 (+786.6%).

Value
$650K
Shares
1,625,000
Price
$0.4000
Role
CEO and Chairman
Holding change
+786.6%
Trade date
Sep 25, 2026
6:07 AM ET 8-K
Financial Results Tamboran Resources Corp TBN

Tamboran Resources Financial Results

Tamboran Resources Corporation reported its financial and operating results for the fourth quarter of fiscal year 2026, ended June 30, 2026. The company released an earnings presentation and press release detailing its performance in the Beetaloo Basin. The filing includes management's forward-looking strategy regarding future production, reserves, and infrastructure development.

Term
Q4 2026
6:06 AM ET Form 4
Insider Selling Keysight Technologies, Inc. KEYS

Keysight Technologies VP and Controller Lisa M. Poole Sells $69.6K of Stock

Lisa M. Poole, VP and Controller, sold 200 shares of Keysight Technologies, Inc. at $348.01 a share, worth $69.6K in total on Sep 23, 2026. Shares held after the trade: 6,134 (-3.2%).

Value
$69.6K
Shares
200
Price
$348.01
Role
VP and Controller
Holding change
-3.2%
Trade date
Sep 23, 2026
6:02 AM ET Form 4
Insider Buying Studio City International Holdings Ltd MSC

Studio City International Holdings Director Lawrence Yau Lung Ho Buys $206K of Stock

Lawrence Yau Lung Ho, Director, bought 1,043,600 shares of Studio City International Holdings Ltd at $0.1977 a share, worth $206K in total on Sep 23, 2026. Shares held after the trade: 463,391,904 (+0.2%).

Value
$206K
Shares
1,043,600
Price
$0.1977
Role
Director
Holding change
+0.2%
Trade date
Sep 23, 2026
6:02 AM ET 8-K
Leadership Change Box Inc BOX

Box Leadership Change

Eli Berkovitch, the Vice President, Chief Accounting Officer, and Controller of Box, Inc., has resigned effective October 23, 2026, to pursue other opportunities. Dylan Smith, the company's Co-founder and CFO, will assume the role of interim principal accounting officer while a search for a permanent replacement is conducted.

6:02 AM ET 8-K/A
Capacity Expansion Quanome Technologies, Inc. QNME

Quanome Technologies Capacity Expansion: $18.8M Investment

Quanome Technologies entered into an $18.8 million purchase agreement for NVIDIA GPU-powered computing infrastructure to build its first U.S. AI infrastructure hub. The project, managed through its subsidiary XDT, aims to launch an AI cloud business providing managed access to computing capacity starting in Q4 2026.

Value
$18.8M
Counterparty
XDT Infrastructure I, LLC
6:02 AM ET 8-K
Reverse Stock Split PLAYSTUDIOS, Inc. MYPS

PLAYSTUDIOS Reverse Stock Split

PLAYSTUDIOS announced a 1-for-10 reverse stock split effective September 30, 2026, to regain compliance with Nasdaq's $1.00 minimum bid price requirement. The company also disclosed it has repurchased 4.3 million shares for $3.0 million during the third quarter of 2026. Split-adjusted trading is expected to begin on October 1, 2026.

6:02 AM ET 8-K
Stock Buyback News Corp NWSA

News Announces $1B Stock Buyback

News Corp provided a daily update on its $1 billion stock repurchase program as required by the Australian Securities Exchange (ASX). The program authorizes the company to buy back outstanding shares of both Class A and Class B common stock from time to time in the open market.

Value
$1B
6:02 AM ET 8-K
Business Update NexPoint Capital, Inc.

NexPoint Capital Business Update

NexPoint Capital, Inc. announced that its net asset value (NAV) per share was determined to be $4.64 as of September 22, 2026. This figure also serves as the price at which the company will issue shares under its distribution reinvestment plan (DRP).

6:01 AM ET 8-K
Executive Compensation Mosaic Co MOS

Mosaic Executive Compensation

The Mosaic Company appointed Walter F. Precourt, III as Executive Vice President - Operations, effective December 1, 2026, succeeding the retiring Karen A. Swager. Mr. Precourt's compensation package includes a base salary of $710,000, a target bonus of 85% of base salary, and a long-term incentive award valued at $1,725,000, along with a $300,000 promotional RSU grant.

Counterparty
Walter F. Precourt, III
6:01 AM ET 8-K
Executive Compensation Boxabl Inc. BXBL

Boxabl Executive Compensation

BOXABL Inc. appointed Timothy Goldsmith, a former Ernst & Young audit partner, to its Board of Directors as the new Audit Committee Chair. Mr. Goldsmith will receive an annual cash retainer of $75,000 plus an additional $26,000 for committee roles, along with $175,000 in Restricted Stock Units with a one-year vesting period. The appointment is part of the company's effort to strengthen its governance and financial infrastructure following its transition to a public company.

Counterparty
Timothy Goldsmith
Term
1 year
6:01 AM ET 8-K
Shareholder Meeting OpenWorld, Inc. OPNW

VerifyMe Shareholder Meeting

VerifyMe, Inc. held its 2026 Annual Meeting of Stockholders where shareholders approved the issuance of common stock for the pending merger with Open World, Ltd. and ratified the election of five directors. Stockholders also approved an amendment to the 2020 Equity Incentive Plan to increase authorized shares, though they did not approve a proposal to authorize a new class of 'blockchain common stock'.

Counterparty
Open World, Ltd.
6:00 AM ET 8-K/A
Leadership Change Clover Health Investments, Corp. CLOV

Clover Health Investments Leadership Change

Clover Health has appointed former U.S. Senator Robert Torricelli and Dr. Brian J. Miller to its Board of Directors, filling two previously disclosed vacancies. Senator Torricelli will serve on the Audit Committee, while Dr. Miller joins the Clinical Committee, bringing the total board count to nine directors. The appointments aim to strengthen the company's expertise in federal policy, clinical medicine, and Medicare Advantage regulation.

6:00 AM ET 8-K
Loan & Debt Jaguar Health, Inc. JAGX

Jaguar Health $6.73M Debt Financing with Streeterville Capital, LLC

Jaguar Health entered into exchange agreements with Streeterville Capital to reduce its outstanding debt by approximately $6.73 million through the issuance of common stock. Specifically, the company issued 182,091 shares to reduce a 2021 note by $1.68 million and 547,898 shares to fully pay off and cancel a 2025 note valued at $5.05 million.

Value
$6.73M
Counterparty
Streeterville Capital, LLC
9:50 PM ET Form 4
Insider Selling Mineralys Therapeutics, Inc. MLYS

Mineralys Therapeutics Insider Brian Taylor Slingsby Sells $3.01M of Stock

Brian Taylor Slingsby sold 104,320 shares of Mineralys Therapeutics, Inc. at $28.81 a share, worth $3.01M in total on Sep 22, 2026. Shares held after the trade: 7,805,718 (-1.3%).

Value
$3.01M
Shares
104,320
Price
$28.81
Holding change
-1.3%
Trade date
Sep 22, 2026
9:36 PM ET Form 4
Insider Selling Photronics Inc PLAB

Photronics Director Kang Jyh Lee Sells $297K of Stock

Kang Jyh Lee, Director, sold 10,000 shares of Photronics Inc at $29.70 a share, worth $297K in total on Sep 22, 2026. Shares held after the trade: 354,850 (-2.7%).

Value
$297K
Shares
10,000
Price
$29.70
Role
Director
Holding change
-2.7%
Trade date
Sep 22, 2026
9:01 PM ET Form 4
Insider Selling Omeros Corp OMER

Omeros VP, Finance & CAO David J. Borges Sells $419K of Stock

David J. Borges, VP, Finance & CAO, sold 20,000 shares of Omeros Corp at $20.95 a share, worth $419K in total between Sep 22, 2026 and Sep 23, 2026. Shares held after the trade: 0 (-100.0%).

Value
$419K
Shares
20,000
Average price
$20.95
Role
VP, Finance & CAO
Holding change
-100.0%
Trade date
Sep 22, 2026 to Sep 23, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.